Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Non-Current Assets (2016 - 2025)

Marimed (MRMD) has disclosed Other Non-Current Assets for 13 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets fell 90.5% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 90.5% decrease, with the full-year FY2024 number at $11.2 million, down 10.51% from a year prior.
  • Other Non-Current Assets was $1.1 million for Q3 2025 at Marimed, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $13.0 million in Q1 2024 to a low of $97950.0 in Q2 2021.
  • A 5-year average of $4.2 million and a median of $1.1 million in 2025 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 1229.59% in 2023, then crashed 91.39% in 2025.
  • Marimed's Other Non-Current Assets stood at $98000.0 in 2021, then soared by 944.9% to $1.0 million in 2022, then skyrocketed by 1124.32% to $12.5 million in 2023, then fell by 10.51% to $11.2 million in 2024, then tumbled by 90.6% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Other Non-Current Assets are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).